Summary
- Current Price
- As of today, KYTX price is $8.87, up +1.14% on
- Current Price All-Time High
- KYTX price is currently -71.01% below its historical high of $30.60 set on
- Market Cap
- KYTX current market cap is $529M, up +468.99% over the past 365 days
- PE Ratio
- KYTX PE ratio is unknown
- Revenue
- KYTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for KYTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Kyverna Therapeutics, Inc. |
| Ticker | NASDAQ: KYTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | kyvernatx.com |
| Employees | 119 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $8.87 | |
| Price, 1D Change | +1.14% | |
| $529M | ||
| - | ||
| - | ||
| 1.64 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.64 | ||
| EPS, 1Y Change | -9.60% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.64 | ||
| EPS Estimate | N/A | -$2.92 |
| EPS Est. Change | N/A | +19.76% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $8.87 | |
| Price Target | - | $32.00 |
| Price Tgt. Change | - | +260.77% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.28 | -$3.33 | -1.42% | |
| -$3.70 | -$3.64 | +1.38% | |
| -$2.92 | N/A | +19.76% | |
| -$2.85 | N/A | +21.84% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $12.84M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $8.87 | |
| $6.43 | ||
| SMA 200 vs Price | -27.56% | |
| $8.28 | ||
| SMA 50 vs Price | -6.66% | |
| 1.64 | ||
| $0.65 | ||
| 57.14 | ||
| 88.90% | ||
| 110.76% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$3.64 | ||
| -$1.80M | ||
| - | ||
| -$169.18M | ||
| - | ||
| -$161.31M | ||
| - | ||
| -$167.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.13 | ||
| 7.75 | ||
| 7.75 | ||
| - | ||
| - | ||
| 2.15 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 2.28 | ||
| -1.66 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $232.28M | ||
| $279.25M | ||
| $294.95M | ||
| $282.95M | ||
| $62.68M | ||
| $36.49M | ||
| $29.03M | ||
| $3.97M | ||
| $5.31M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $161.31M | ||
| $167.38M | ||
| $1.80M | ||
| $0.00 | ||
| $1.80M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$153.71M | ||
| $40.02M | ||
| $141.17M | ||
| $1.13M | ||
| -$154.85M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| Morgan Stanley | → | |
| Wells Fargo | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | → | |
| HC Wainwright & Co. | → | |
| William Blair | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Morgan Stanley | → |
Analyst sentiment
Institutional ownership
Screeners with KYTX
FAQ
What is the ticker symbol for Kyverna Therapeutics, Inc.?
The ticker symbol for Kyverna Therapeutics, Inc. is NASDAQ:KYTX
Does Kyverna Therapeutics, Inc. pay dividends?
No, Kyverna Therapeutics, Inc. does not pay dividends
What sector is Kyverna Therapeutics, Inc. in?
Kyverna Therapeutics, Inc. is in the Healthcare sector
What industry is Kyverna Therapeutics, Inc. in?
Kyverna Therapeutics, Inc. is in the Biotechnology industry
What country is Kyverna Therapeutics, Inc. based in?
Kyverna Therapeutics, Inc. is headquartered in United States
When did Kyverna Therapeutics, Inc. go public?
Kyverna Therapeutics, Inc. initial public offering (IPO) was on February 9, 2024
Is Kyverna Therapeutics, Inc. in the S&P 500?
No, Kyverna Therapeutics, Inc. is not included in the S&P 500 index
Is Kyverna Therapeutics, Inc. in the NASDAQ 100?
No, Kyverna Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Kyverna Therapeutics, Inc. in the Dow Jones?
No, Kyverna Therapeutics, Inc. is not included in the Dow Jones index
When was Kyverna Therapeutics, Inc. last earnings report?
Kyverna Therapeutics, Inc.'s most recent earnings report was on November 12, 2025
When does Kyverna Therapeutics, Inc. report earnings?
The next expected earnings date for Kyverna Therapeutics, Inc. is May 13, 2026
Data Sources & References
- KYTX Official Website kyvernatx.com
- KYTX Profile on Yahoo Finance finance.yahoo.com/quote/KYTX
- KYTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/kytx